Corneal Collagen Cross-Linking with Riboflavin
<p>Corneal collagen cross-linking is an in-office eye procedure that may be performed by Dr. Goosey for patients whose corneas have been weakened by conditions such as keratoconus, other corneal diseases, or, in very rare cases, complications from LASIK surgery. This advanced treatment uses UV light and a photosensitizer to strengthen the cornea by creating stronger chemical bonds. The goal of the treatment is to slow down the progressive of irregular corneal changesi, commonly known as ectasia. These changes are typically marked by corneal thinning and an increase in the corneal curvature.</p>
The corneal cross-linking procedure is relatively non-invasive, involving the application of liquid riboflavin (vitamin B2)to the eyes, followed by controlled exposure to UV light. This technique can be combined with other procedures for keratoconus treatment. As an experienced cornea specialist, Dr. Goosey has treated thousands of patients with the best in quality corneal care. If you or a loved one are struggling with keratoconus or similar vision issues, there is no better eye surgeon than Dr. Goosey!
Read more information below on cross-linking.
The following information has been provided with permission from the National Keratoconus Foundation (NKCF)
Understanding Corneal Collagen Cross-Linking
This treatment increases the natural collagen cross-links within the cornea, which act as “anchors” to prevent the cornea from bulging and becoming misshapen. By increasing these cross-links, corneal cross-linking helps to stabilize the cornea and slow the progression of keratoconus.
During the procedure, custom-made riboflavin drops are applied to the cornea and then activated with UV light. Clinical studies have shown that this process strengthens the cornea by enhancing collagen cross-linking.
It is important to note that corneal cross-linking is not a cure for keratoconus, but rather a method to halt its progression and prevent further deterioration in vision and reducing the need for future corneal transplantation.
Developed in Germany
The procedure was developed at the Technische Universität Dresden in Germany and has been shown in European studies to slow or arrest the progression of keratoconus. Dr. Goosey offers this advanced treatment to help patients protect their vision and avoid further complications.